| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/21/1999 | EP0909274A1 Methods for purification and use of erythropoietin binding protein |
| 04/21/1999 | EP0909273A1 A transcription factor |
| 04/21/1999 | EP0909272A1 Helicobacter pylori adhesin binding group antigen |
| 04/21/1999 | EP0909181A1 Novel compounds |
| 04/21/1999 | EP0909180A1 Novel compounds |
| 04/21/1999 | EP0909179A2 T-cell dependent vaccine and the cell surface receptor cd28 |
| 04/21/1999 | EP0692981B1 Chelators of type xn 1?s 1?x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses |
| 04/21/1999 | EP0692980B1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use |
| 04/21/1999 | EP0692976B1 Chelating agents of the type xn 1?s 1?o 1? for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy |
| 04/21/1999 | EP0674660B1 Multifunctional neurotrophic factors |
| 04/21/1999 | EP0609280B1 Human il-3 variants |
| 04/21/1999 | EP0565607B1 Protection group, compoud protected by this group and device for grafting the protection group onto the compound being protected |
| 04/21/1999 | EP0513054B1 Virus/herbicide resistance genes process for producing same and their use |
| 04/21/1999 | CN1214736A Promoter from tobacco |
| 04/21/1999 | CN1214735A IgA nephropathy-associated gene |
| 04/21/1999 | CN1214734A SCF analog compositions and method |
| 04/21/1999 | CN1214733A Down-regualtion resistant C3 convertase |
| 04/21/1999 | CN1214694A Peptides with antiproliferative properties |
| 04/21/1999 | CN1214693A Novel protein |
| 04/21/1999 | CN1214692A Tumor rejection antigens presented by HLA-B44 molecules and uses thereof |
| 04/21/1999 | CN1214689A Method of producing IGF-I and IGFBP-3 with correct folding and disulfide bonding |
| 04/21/1999 | CN1214624A Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins |
| 04/21/1999 | CN1214615A Ice crystal growth inhibiting agents |
| 04/21/1999 | CN1214195A Disease resistant plant including thionin gene |
| 04/21/1999 | CA2248169A1 Dnag |
| 04/20/1999 | US5895833 Gene expression compatible with mammary glands |
| 04/20/1999 | US5895810 Stable polymerized hemoglobin and use thereof |
| 04/20/1999 | US5895759 Vector for gene transfer in liver cells |
| 04/20/1999 | US5895756 Non-antibiotic system for selection of recombinant mycobacteria |
| 04/20/1999 | US5895755 Platelet derived growth factor |
| 04/20/1999 | US5895754 Cdna coding for soluble polypeptide with deletion of cytoplasmic and/or transmembrane domain; for screening assays of suppressors of osteoclast function and bone reabsorption |
| 04/20/1999 | US5895747 Screening molecules which suppress activator enhancement of transcription factors containing basic region/leucine zipper domains binding to dna; anticarcinogenic agents; viricides |
| 04/20/1999 | US5895746 Immunoassay for detecting label bound to intact trimeric alpha1-homotrimeric peptide isolated without use of proteolytic enzymes |
| 04/20/1999 | US5895655 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens |
| 04/20/1999 | US5895651 Recombinant dengue virus envelope protein/maltose-binding protein antigens and subunit vaccine compositions containing said antigens |
| 04/20/1999 | US5895650 Prevention and treatment of retroviral disease |
| 04/20/1999 | US5895646 Having specific activity in the human bone marrow assay |
| 04/20/1999 | CA2133649C Oral infection of insect larvae with pre-occluded baculovirus particles |
| 04/20/1999 | CA2128230C Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| 04/20/1999 | CA1340506C Production of gonorrheal pi proteins and vaccines |
| 04/20/1999 | CA1340505C Bovine placental lactogen |
| 04/15/1999 | WO1999018441A1 Icam-4 and diagnostic uses thereof |
| 04/15/1999 | WO1999018243A1 Signal peptide containing proteins and uses therefor |
| 04/15/1999 | WO1999018235A1 Process for detecting, extracting or removing human or mammalian cells with a disturbed cellular cycle regulation or unlimited proliferation or tumour-forming ability |
| 04/15/1999 | WO1999018230A2 Method to detect mrit and bcl-2 or caspase association alterations |
| 04/15/1999 | WO1999018226A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/15/1999 | WO1999018225A1 Expression of cholera toxin b subunit in transgenic plants and efficacy thereof in oral vaccines |
| 04/15/1999 | WO1999018221A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | WO1999018220A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 04/15/1999 | WO1999018216A2 Chimeric vaccine against tick-borne encephalitis virus |
| 04/15/1999 | WO1999018215A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
| 04/15/1999 | WO1999018214A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 04/15/1999 | WO1999018213A1 MUTANTS OF YEAST Cdc24p, DEFECTIVE IN BINDING OF THE G-PROTEIN BETA SUBUNIT |
| 04/15/1999 | WO1999018211A1 Yeast cells expressing modified g proteins and methods of use therefor |
| 04/15/1999 | WO1999018210A2 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
| 04/15/1999 | WO1999018209A1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a |
| 04/15/1999 | WO1999018208A1 101 human secreted proteins |
| 04/15/1999 | WO1999018207A1 Human hox c10 and polynucleotides encoding |
| 04/15/1999 | WO1999018206A2 Human cancer antigen ny eso-1/cag-3 and gene encoding same |
| 04/15/1999 | WO1999018205A1 POLYPEPTIDE, cDNA ENCODING THE SAME, AND USE OF THEM |
| 04/15/1999 | WO1999018204A2 HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND cDNAS ENCODING THESE PROTEINS |
| 04/15/1999 | WO1999018203A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS |
| 04/15/1999 | WO1999018202A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS |
| 04/15/1999 | WO1999018201A1 Gankyrin |
| 04/15/1999 | WO1999018200A1 PROTEINS ALIKE TO HUMAN COMPLEMENT FACTOR H AND cDNAs ENCODING THESE PROTEINS |
| 04/15/1999 | WO1999018199A2 cDNAs CODING FOR HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS |
| 04/15/1999 | WO1999018198A1 Hepatitis c receptor protein cd81 |
| 04/15/1999 | WO1999018197A2 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced) |
| 04/15/1999 | WO1999018196A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
| 04/15/1999 | WO1999018195A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 04/15/1999 | WO1999018194A1 GENE DELETED RECOMBINANT FeLV PROVIRAL DNA FOR PRODUCTION OF VACCINES AGAINST FeLV |
| 04/15/1999 | WO1999018193A1 Jnk3 modulators and methods of use |
| 04/15/1999 | WO1999018191A1 Transgenic animals with knocked-in vec receptor genes and uses thereof |
| 04/15/1999 | WO1999018190A1 Animal model for fatty acid transport |
| 04/15/1999 | WO1999018187A1 NOVEL clpL |
| 04/15/1999 | WO1999018169A1 Methods of using ice-controlling molecules |
| 04/15/1999 | WO1999018129A1 Soluble single-chain t-cell receptor proteins |
| 04/15/1999 | WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | WO1999018127A1 Secreted proteins and polynucleotides encoding them |
| 04/15/1999 | WO1999018126A1 POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH |
| 04/15/1999 | WO1999018125A1 Human facilitative glucose transport protein glut8 |
| 04/15/1999 | WO1999018124A1 Assays for nuclear receptor ligands using fret |
| 04/15/1999 | WO1999018123A1 Use of neuronal and lymphocytic potassium canal inhibitors for treating neurological diseases of immune origin |
| 04/15/1999 | WO1999018122A1 Ama |
| 04/15/1999 | WO1999018121A1 Method for the covalent attachment of polysaccharides to protein molecules |
| 04/15/1999 | WO1999018117A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus |
| 04/15/1999 | WO1999018115A1 Polynucleotide sequences from candida albicans encoding polypeptides associated with filamentous growth |
| 04/15/1999 | WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | WO1999017798A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | WO1999017796A2 Modulation of lerk-2-mediated cell adhesion |
| 04/15/1999 | WO1999017795A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 04/15/1999 | WO1999017794A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
| 04/15/1999 | WO1999017791A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | WO1999017789A1 Peptide compositions for the treatment and prevention of hiv infection |
| 04/15/1999 | WO1999017786A1 Mammalian-derived peptides for the treatment of microbial infection |
| 04/15/1999 | WO1999017785A1 Reptilian-derived peptides for the treatment of microbial infection |
| 04/15/1999 | WO1999017741A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | WO1999017740A1 Peptide/lipid complex formation by co-lyophilization |
| 04/15/1999 | WO1999017616A1 Structure-based rational design of compounds to inhibit papillomavirus infection |